Literature DB >> 14987375

Molecular pathology of von HippelLindau disease and the VHL tumour suppressor gene.

F M Richards1.   

Abstract

Entities:  

Year:  2001        PMID: 14987375     DOI: 10.1017/S1462399401002654

Source DB:  PubMed          Journal:  Expert Rev Mol Med        ISSN: 1462-3994            Impact factor:   5.600


× No keyword cloud information.
  12 in total

1.  Expression of hypoxia-inducible factor-1alpha and -2alpha in human choroidal neovascular membranes.

Authors:  Carl M Sheridan; Stephanie Pate; Paul Hiscott; David Wong; David M Pattwell; David Kent
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-07-10       Impact factor: 3.117

2.  von Hippel-Lindau mutation in mice recapitulates Chuvash polycythemia via hypoxia-inducible factor-2alpha signaling and splenic erythropoiesis.

Authors:  Michele M Hickey; Jennifer C Lam; Natalie A Bezman; W Kimryn Rathmell; M Celeste Simon
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

3.  Functional erythropoietin autocrine loop in melanoma.

Authors:  Suresh M Kumar; Geza Acs; Dong Fang; Meenhard Herlyn; David E Elder; Xiaowei Xu
Journal:  Am J Pathol       Date:  2005-03       Impact factor: 4.307

4.  Novel homozygous VHL mutation in exon 2 is associated with congenital polycythemia but not with cancer.

Authors:  Lucie Lanikova; Felipe Lorenzo; Chunzhang Yang; Hari Vankayalapati; Richard Drachtman; Vladimir Divoky; Josef T Prchal
Journal:  Blood       Date:  2013-03-28       Impact factor: 22.113

5.  Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma.

Authors:  Iris J H van Vlodrop; Marcella M L Baldewijns; Kim M Smits; Leo J Schouten; Leander van Neste; Wim van Criekinge; Hein van Poppel; Evelyne Lerut; Kornel E Schuebel; Nita Ahuja; James G Herman; Adriaan P de Bruïne; Manon van Engeland
Journal:  Am J Pathol       Date:  2009-12-30       Impact factor: 4.307

6.  Prevalence of von Hippel-Lindau gene mutations in sporadic renal cell carcinoma: results from The Netherlands cohort study.

Authors:  Kjeld P van Houwelingen; Boukje A C van Dijk; Christina A Hulsbergen-van de Kaa; Leo J Schouten; Hanneke J M Gorissen; Jack A Schalken; Piet A van den Brandt; Egbert Oosterwijk
Journal:  BMC Cancer       Date:  2005-06-02       Impact factor: 4.430

7.  HIF2A germline-mutation-induced polycythemia in a patient with VHL-associated renal-cell carcinoma.

Authors:  Qiuli Liu; Dali Tong; Gaolei Liu; Yuting Yi; Dianzheng Zhang; Jun Zhang; Yao Zhang; Zaoming Huang; Yaoming Li; Rongrong Chen; Yanfang Guan; Xin Yi; Jun Jiang
Journal:  Cancer Biol Ther       Date:  2017-11-27       Impact factor: 4.742

Review 8.  Prognostic and predictive value of VHL gene alteration in renal cell carcinoma: a meta-analysis and review.

Authors:  Bum Jun Kim; Jung Han Kim; Hyeong Su Kim; Dae Young Zang
Journal:  Oncotarget       Date:  2017-02-21

9.  Identification of 3 novel VHL germ-line mutations in Danish VHL patients.

Authors:  Mette Dandanell; Lennart Friis-Hansen; Lone Sunde; Finn C Nielsen; Thomas V O Hansen
Journal:  BMC Med Genet       Date:  2012-07-16       Impact factor: 2.103

Review 10.  The Role of Hypoxia and Cancer Stem Cells in Renal Cell Carcinoma Pathogenesis.

Authors:  Adam Myszczyszyn; Anna M Czarnecka; Damian Matak; Lukasz Szymanski; Fei Lian; Anna Kornakiewicz; Ewa Bartnik; Wojciech Kukwa; Claudine Kieda; Cezary Szczylik
Journal:  Stem Cell Rev Rep       Date:  2015-12       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.